Article(id=1329528300285834067, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329528206224371871, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.10.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1718294400000, receivedDateStr=2024-06-14, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794913848228, onlineDateStr=2026-11-17, pubDate=1728489600000, pubDateStr=2024-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794913848228, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794913848228, creator=13701087609, updateTime=1794913848228, updator=13701087609, issue=Issue{id=1329528206224371871, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='10', pageStart='1005', pageEnd='1103', issueExtLink='null', onlineDate='null', pubDate='1728489600000', pubDateStr='2024-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794913825793, creator='13701087609', updateTime=1794962211707, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329731151817716055, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329528206224371871, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329731151817716056, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329528206224371871, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1099, endPage=1103, ext={EN=ArticleExt(id=1329528300474577748, articleId=1329528300285834067, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of semaglutide in the treatment of cardiovascular diseases complicated with obesity, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Semaglutide was approved by the U.S. Food and Drug Administration on March 8, 2024 for the prevention of cardiovascular disease, heart disease, and cerebral apoplexy in adults who are overweight or obese. Semaglutide improves blood glucose and traditional cardiovascular moderate risk factor levels in obese patients, reduces ectopic adipose tissue that can lead to atherosclerosis and myocardial dysfunction, and improves the systemic pro-inflammatory and pro-thrombotic environment associated with obesity. This article intended to elaborate the mechanism of action, clinical research and safety of semaglutide in the treatment of cardiovascular diseases complicated with obesity from multiple ways and levels, so as to provide certain reference for clinical use.

, authors=Qing MA, Jianqi JIA, Qian HE, authorsList=Qing MA, Jianqi JIA, Qian HE, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329528300822704981, articleId=1329528300285834067, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=司美格鲁肽治疗合并肥胖的心血管疾病研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

司美格鲁肽(semaglutide)于2024年3月8日获美国食品药品监督管理局批准用于超重或肥胖(obesity)的成年人群心血管疾病、心脏病及脑卒中(cerebral apoplexy)等的预防。司美格鲁肽可改善肥胖患者的血糖和传统心血管中等风险因子水平,并减少可能导致动脉粥样硬化(atheroscherosis)和心肌功能障碍的异位脂肪组织,改善与肥胖相关的全身性促炎及促血栓形成环境。现拟从多途径、多层次阐述司美格鲁肽治疗合并肥胖的心血管疾病作用机制、临床研究及安全性,为临床用药提供一定参考。

, authors=马庆, 贾建旗, 何倩, authorsList=马庆, 贾建旗, 何倩, authorCompany=null, correspAuthors=null, authorNote=

马庆,主管药师,研究方向:临床药理学。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=LfmbLAGSRb31uGqZ0EbvUg==, magXml=80x9wJCOuDxw/3yVc0UsYQ==, pdfUrl=null, pdf=vuWiwMGsxrDCRbw+hzN06g==, pdfFileSize=2011302, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=tJY+ACsmzUZgZNuSb/qjFg==, mapNumber=null, fund=null)}, authors=[Author(id=1329528301212775258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329528301300855644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301212775258, language=EN, stringName=Qing MA, firstName=Qing, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329528301456044893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301212775258, language=CN, stringName=马庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003, bio={"content":"

马庆,主管药师,研究方向:临床药理学。

"}, bioImg=null, bioContent=

马庆,主管药师,研究方向:临床药理学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])]), Author(id=1329528301531542367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329528301611234145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301531542367, language=EN, stringName=Jianqi JIA, firstName=Jianqi, middleName=null, lastName=JIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329528301686731618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301531542367, language=CN, stringName=贾建旗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])]), Author(id=1329528301758034788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329528301825143654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301758034788, language=EN, stringName=Qian HE, firstName=Qian, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329528301896446823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301758034788, language=CN, stringName=何倩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])])], keywords=[Keyword(id=1329528302047441768, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, language=EN, orderNo=1, keyword=semaglutide), Keyword(id=1329528302156493673, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, language=EN, orderNo=2, keyword=obesity), Keyword(id=1329528302240379754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, language=EN, orderNo=3, keyword=cardiovascular disease), Keyword(id=1329528302328460139, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, language=CN, orderNo=1, keyword=司美格鲁肽), Keyword(id=1329528302458483564, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, language=CN, orderNo=2, keyword=肥胖), Keyword(id=1329528302538175341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, language=CN, orderNo=3, keyword=心血管疾病)], refs=[Reference(id=1329528302643032942, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=World Obesity Federation. World Obesity Atlas 2024[R]. London: World Obesity Federation, 2024. https://data.worldo-besity.org/publications/?cat=22., articleTitle=null, refAbstract=null), Reference(id=1329528302714336111, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Li X, Zhu J, Zhao W, et al. The causal effect of obesity on the risk of 15 autoimmune diseases: a Mendelian randomization study[J]. Obes Facts, 2023, 16(6): 598-605., articleTitle=null, refAbstract=null), Reference(id=1329528302781444976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=田露, 薛浩. 肥胖与心血管疾病的研究进展[J]. 中华全科医师杂志, 2024, 23(3): 305-308., articleTitle=null, refAbstract=null), Reference(id=1329528302848553841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Michael LA, Kirstine BF, Mc H, et al. Semaglutide and car-diovascular outcomes in obesity without diabetes[J]. NEJM, 2023, doi: 10.1056/NEJMoa2307563., articleTitle=null, refAbstract=null), Reference(id=1329528304463360882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhao X, Wang MH, Wen ZT, et al. GLP-1 receptor agonists: beyond their pancreatic effects[J]. Front Endocrinol (Lausanne), 2021, 12: 721135., articleTitle=null, refAbstract=null), Reference(id=1329528304547246963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=纪立农. 胰高血糖素样肽1受体激动剂周制剂中国证据与专家指导建议[J]. 中国糖尿病杂志, 2022, 30(6): 405-411., articleTitle=null, refAbstract=null), Reference(id=1329528304631133044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide[J]. Front Endocrinol (Lausanne), 2019, 10: 155., articleTitle=null, refAbstract=null), Reference(id=1329528304710824821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Hachula M, Kosowski M, Ryl S, et al. Impact of glucagon-like peptide 1 receptor agonists on biochemical markers of the initiation of atherosclerotic process[J]. Int J Mol Sci, 2024, 25(3): 1854., articleTitle=null, refAbstract=null), Reference(id=1329528304794710902, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=朱秋霞. 司美格鲁肽通过激活PKG/PKCε/ERK1/2通路抑制心肌细胞缺血/再灌注诱导的凋亡[D]. 泸州: 西南医科大学, 2024., articleTitle=null, refAbstract=null), Reference(id=1329528304861819767, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Goldenberg RM, Teoh H, Verma S. Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-ag-onists for cardioprotection, type 2 diabetes and obesity: a re-view of mechanisms and clinical data[J]. Curr Opin Cardiol, 2023, 38(6): 539-545., articleTitle=null, refAbstract=null), Reference(id=1329528304937317240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity[J]. N Engl J Med, 2023, 389(12): 1069-1084., articleTitle=null, refAbstract=null), Reference(id=1329528305004426105, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=El Meouchy P, Wahoud M, Allam S, et al. Hypertension related to obesity: pathogenesis, characteristics and factors for control[J]. Int J Mol Sci, 2022, 23(20): 12305., articleTitle=null, refAbstract=null), Reference(id=1329528305088312186, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=王歆烨, 崔萌萌, 赵刚, 等. 司美格鲁肽治疗2型糖尿病心血管并发症的研究进展[J]. 心血管病学进展, 2023, 44(8): 733-737., articleTitle=null, refAbstract=null), Reference(id=1329528305168003963, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=黄恺, 段宇辰. 胰高血糖素样肽-1受体激动剂防治成人2型糖尿病合并动脉粥样硬化性心血管疾病的中国专家共识[J]. 临床心血管病杂志, 2023, 39(9): 651-660., articleTitle=null, refAbstract=null), Reference(id=1329528305289638780, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Bułdak Ł. Cardiovascular diseases-a focus on atherosclerosis, its prophylaxis, complications and recent advancements in therapies[J]. Int J Mol Sci, 2022, 23(9): 4695., articleTitle=null, refAbstract=null), Reference(id=1329528305352553341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Ozbeyaz NB, Gokalp G, Algul E, et al. Could systemic inflammation in healthy individuals with obesity indicate sub-clinical atherosclerosis?[J]. Angiology, 2023, 74(1): 62-69., articleTitle=null, refAbstract=null), Reference(id=1329528305432245118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=赵越. 超重/肥胖与动脉粥样硬化发生的研究进展[J]. 公共卫生与预防医学, 2024, 35(1): 129-132., articleTitle=null, refAbstract=null), Reference(id=1329528305503548287, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Jensen JK, Binderup T, Grandjean CE, et al. Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis[J]. Atherosclerosis, 2022, 352: 88-95., articleTitle=null, refAbstract=null), Reference(id=1329528305587434368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=García-Vega D, Sánchez-López D, Rodríguez-Carnero G, et al. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network[J]. Cardiovasc Diabetol, 2024, 23(1): 1., articleTitle=null, refAbstract=null), Reference(id=1329528305696486273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Bostrom JA, Mottel B, Heffron SP. Medical and surgical obesity treatments and atherosclerosis: mechanisms beyond typical risk factors[J]. Curr Atheroscler Rep, 2021, 23(10): 60., articleTitle=null, refAbstract=null), Reference(id=1329528305763595138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Gallo G, Volpe M. Potential mechanisms of the protective effects of the cardiometabolic drugs type-2 sodium-glucose transporter inhibitors and glucagon-like peptide-1 receptor agonists in heart failure[J]. Int J Mol Sci, 2024, 25(5): 2484., articleTitle=null, refAbstract=null), Reference(id=1329528305826509699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu X, Wang Y, Hu X. Association of weight loss with cardio-vascular or all-cause mortality in patients with heart failure: a meta-analysis[J]. Int J Obes (Lond), 2024, 48(5): 626-634., articleTitle=null, refAbstract=null), Reference(id=1329528305889424260, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Jamaly S, Carlsson L, Peltonen M, et al. Heart failure devel-opment in obesity: underlying risk factors and mechanistic pathways[J]. ESC Heart Fail, 2021, 8(1): 356-367., articleTitle=null, refAbstract=null), Reference(id=1329528305956533125, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Antonopoulos AS, Papastamos C, Cokkinos DV, et al. Epi-cardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes[J]. Curr Probl Cardiol, 2023, 48(10): 101841., articleTitle=null, refAbstract=null), Reference(id=1329528306027836294, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF pheno-type[J]. JACC Heart Fail, 2023, 11(8 Pt 1): 1000-1010., articleTitle=null, refAbstract=null), Reference(id=1329528306107528071, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Kosiborod MN, Verma S, Borlaug BA, et al. Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial[J]. Circulation, 2024, 149(3): 204-216., articleTitle=null, refAbstract=null), Reference(id=1329528306178831240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Kobak KA, Chiao YA. Semaglutide in heart failure with pre-served ejection fraction: benefits above and beyond weight loss[J]. JACC Basic Transl Sci, 2023, 8(10): 1315-1317., articleTitle=null, refAbstract=null), Reference(id=1329528306262717321, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Withaar C, Meems LMG, Nollet EE, et al. The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF[J]. JACC Basic Transl Sci, 2023, 8(10): 1298-1314., articleTitle=null, refAbstract=null), Reference(id=1329528306329826186, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial[J]. J Am Med Assoc, 2021, 325(14): 1414-1425., articleTitle=null, refAbstract=null), Reference(id=1329528306396935051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Smits MM, van Raalte DH. Safety of semaglutide[J]. Front Endocrinol (Lausanne), 2021, 12: 645563., articleTitle=null, refAbstract=null), Reference(id=1329528306468238220, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Romera I, Cebrián-Cuenca A, Álvarez-Guisasola F, et al. A review of practical issues on the use of glucagon-like peptide-1 receptor agonists for the management of type 2 diabetes[J]. Diabetes Ther, 2019, 10(1): 5-19., articleTitle=null, refAbstract=null), Reference(id=1329528306547929997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Masson W, Lobo M, Barbagelata L, et al. Acute pancreatitis due to different semaglutide regimens: an updated meta-analysis[J]. Endocrinol Diabetes Nutr (Engl Ed), 2024, 71(3): 124-132., articleTitle=null, refAbstract=null), Reference(id=1329528306627621774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Nagendra L, Bg H, Sharma M, et al. Semaglutide and cancer: a systematic review and meta-analysis[J]. Diabetes Metab Syndr, 2023, 17(9): 102834., articleTitle=null, refAbstract=null), Reference(id=1329528306719896463, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Ouellette S, Frias G, Shah R, et al. Dermal hypersensitivity reaction to semaglutide: two case reports[J]. J Drugs Dermatol, 2023, 22(4): 413-416., articleTitle=null, refAbstract=null), Reference(id=1329528306837336976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=He L, Wang J, Ping F, et al. Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials[J]. J Am Med Assoc Intern Med, 2022, 182(5): 513-519., articleTitle=null, refAbstract=null), Reference(id=1329528306917028753, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=赵翊如, 方振威, 张琳, 等. 基于FAERS数据库的成人使用司美格鲁肽的临床研究[J]. 中国临床药理学杂志, 2024, 40(2): 264-268., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.10.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.10.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.10.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.10.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1728489600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
司美格鲁肽治疗合并肥胖的心血管疾病研究进展
马庆 , 贾建旗 , 何倩
世界临床药物 | 综述评论 2024,45(10): 1099-1103
收起
收藏切换
世界临床药物 |综述评论 2024 , 45 (10) : 1099 -1103
司美格鲁肽治疗合并肥胖的心血管疾病研究进展
全屏
[Author(id=1329528301212775258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329528301300855644, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301212775258, language=EN, stringName=Qing MA, firstName=Qing, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329528301456044893, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301212775258, language=CN, stringName=马庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003, bio={"content":"

马庆,主管药师,研究方向:临床药理学。

"}, bioImg=null, bioContent=

马庆,主管药师,研究方向:临床药理学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])]), Author(id=1329528301531542367, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329528301611234145, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301531542367, language=EN, stringName=Jianqi JIA, firstName=Jianqi, middleName=null, lastName=JIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329528301686731618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301531542367, language=CN, stringName=贾建旗, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])]), Author(id=1329528301758034788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329528301825143654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301758034788, language=EN, stringName=Qian HE, firstName=Qian, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329528301896446823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, authorId=1329528301758034788, language=CN, stringName=何倩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329528301103723350, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, xref=null, ext=[AuthorCompanyExt(id=1329528301112111959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China), AuthorCompanyExt(id=1329528301124694872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329528300285834067, companyId=1329528301103723350, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003)])])]
马庆, 贾建旗, 何倩
作者信息
  • 中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003
作者简介:

马庆,主管药师,研究方向:临床药理学。

Research progress of semaglutide in the treatment of cardiovascular diseases complicated with obesity
Qing MA, Jianqi JIA, Qian HE
Affiliations
  • Department of Outpatient, the 989th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Luoyang 471003, Henan Province, China
出版时间: 2024-10-10 doi: 10.13683/j.wph.2024.10.016
文章导航
收藏切换

司美格鲁肽(semaglutide)于2024年3月8日获美国食品药品监督管理局批准用于超重或肥胖(obesity)的成年人群心血管疾病、心脏病及脑卒中(cerebral apoplexy)等的预防。司美格鲁肽可改善肥胖患者的血糖和传统心血管中等风险因子水平,并减少可能导致动脉粥样硬化(atheroscherosis)和心肌功能障碍的异位脂肪组织,改善与肥胖相关的全身性促炎及促血栓形成环境。现拟从多途径、多层次阐述司美格鲁肽治疗合并肥胖的心血管疾病作用机制、临床研究及安全性,为临床用药提供一定参考。

司美格鲁肽  /  肥胖  /  心血管疾病

Semaglutide was approved by the U.S. Food and Drug Administration on March 8, 2024 for the prevention of cardiovascular disease, heart disease, and cerebral apoplexy in adults who are overweight or obese. Semaglutide improves blood glucose and traditional cardiovascular moderate risk factor levels in obese patients, reduces ectopic adipose tissue that can lead to atherosclerosis and myocardial dysfunction, and improves the systemic pro-inflammatory and pro-thrombotic environment associated with obesity. This article intended to elaborate the mechanism of action, clinical research and safety of semaglutide in the treatment of cardiovascular diseases complicated with obesity from multiple ways and levels, so as to provide certain reference for clinical use.

semaglutide  /  obesity  /  cardiovascular disease
马庆, 贾建旗, 何倩. 司美格鲁肽治疗合并肥胖的心血管疾病研究进展. 世界临床药物, 2024 , 45 (10) : 1099 -1103 . DOI: 10.13683/j.wph.2024.10.016
Qing MA, Jianqi JIA, Qian HE. Research progress of semaglutide in the treatment of cardiovascular diseases complicated with obesity[J]. World Clinical Drug, 2024 , 45 (10) : 1099 -1103 . DOI: 10.13683/j.wph.2024.10.016

参考文献 引证文献
排序方式:
[1]
World Obesity Federation. World Obesity Atlas 2024[R]. London: World Obesity Federation, 2024. https://data.worldo-besity.org/publications/?cat=22.
[2]
Li X, Zhu J, Zhao W, et al. The causal effect of obesity on the risk of 15 autoimmune diseases: a Mendelian randomization study[J]. Obes Facts, 2023, 16(6): 598-605.
[3]
田露, 薛浩. 肥胖与心血管疾病的研究进展[J]. 中华全科医师杂志, 2024, 23(3): 305-308.
[4]
Michael LA, Kirstine BF, Mc H, et al. Semaglutide and car-diovascular outcomes in obesity without diabetes[J]. NEJM, 2023, doi: 10.1056/NEJMoa2307563.
[5]
Zhao X, Wang MH, Wen ZT, et al. GLP-1 receptor agonists: beyond their pancreatic effects[J]. Front Endocrinol (Lausanne), 2021, 12: 721135.
[6]
纪立农. 胰高血糖素样肽1受体激动剂周制剂中国证据与专家指导建议[J]. 中国糖尿病杂志, 2022, 30(6): 405-411.
[7]
Knudsen LB, Lau J. The discovery and development of liraglutide and semaglutide[J]. Front Endocrinol (Lausanne), 2019, 10: 155.
[8]
Hachula M, Kosowski M, Ryl S, et al. Impact of glucagon-like peptide 1 receptor agonists on biochemical markers of the initiation of atherosclerotic process[J]. Int J Mol Sci, 2024, 25(3): 1854.
[9]
朱秋霞. 司美格鲁肽通过激活PKG/PKCε/ERK1/2通路抑制心肌细胞缺血/再灌注诱导的凋亡[D]. 泸州: 西南医科大学, 2024.
[10]
Goldenberg RM, Teoh H, Verma S. Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-ag-onists for cardioprotection, type 2 diabetes and obesity: a re-view of mechanisms and clinical data[J]. Curr Opin Cardiol, 2023, 38(6): 539-545.
[11]
Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity[J]. N Engl J Med, 2023, 389(12): 1069-1084.
[12]
El Meouchy P, Wahoud M, Allam S, et al. Hypertension related to obesity: pathogenesis, characteristics and factors for control[J]. Int J Mol Sci, 2022, 23(20): 12305.
[13]
王歆烨, 崔萌萌, 赵刚, 等. 司美格鲁肽治疗2型糖尿病心血管并发症的研究进展[J]. 心血管病学进展, 2023, 44(8): 733-737.
[14]
黄恺, 段宇辰. 胰高血糖素样肽-1受体激动剂防治成人2型糖尿病合并动脉粥样硬化性心血管疾病的中国专家共识[J]. 临床心血管病杂志, 2023, 39(9): 651-660.
[15]
Bułdak Ł. Cardiovascular diseases-a focus on atherosclerosis, its prophylaxis, complications and recent advancements in therapies[J]. Int J Mol Sci, 2022, 23(9): 4695.
[16]
Ozbeyaz NB, Gokalp G, Algul E, et al. Could systemic inflammation in healthy individuals with obesity indicate sub-clinical atherosclerosis?[J]. Angiology, 2023, 74(1): 62-69.
[17]
赵越. 超重/肥胖与动脉粥样硬化发生的研究进展[J]. 公共卫生与预防医学, 2024, 35(1): 129-132.
[18]
Jensen JK, Binderup T, Grandjean CE, et al. Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis[J]. Atherosclerosis, 2022, 352: 88-95.
[19]
García-Vega D, Sánchez-López D, Rodríguez-Carnero G, et al. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network[J]. Cardiovasc Diabetol, 2024, 23(1): 1.
[20]
Bostrom JA, Mottel B, Heffron SP. Medical and surgical obesity treatments and atherosclerosis: mechanisms beyond typical risk factors[J]. Curr Atheroscler Rep, 2021, 23(10): 60.
[21]
Gallo G, Volpe M. Potential mechanisms of the protective effects of the cardiometabolic drugs type-2 sodium-glucose transporter inhibitors and glucagon-like peptide-1 receptor agonists in heart failure[J]. Int J Mol Sci, 2024, 25(5): 2484.
[22]
Wu X, Wang Y, Hu X. Association of weight loss with cardio-vascular or all-cause mortality in patients with heart failure: a meta-analysis[J]. Int J Obes (Lond), 2024, 48(5): 626-634.
[23]
Jamaly S, Carlsson L, Peltonen M, et al. Heart failure devel-opment in obesity: underlying risk factors and mechanistic pathways[J]. ESC Heart Fail, 2021, 8(1): 356-367.
[24]
Antonopoulos AS, Papastamos C, Cokkinos DV, et al. Epi-cardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes[J]. Curr Probl Cardiol, 2023, 48(10): 101841.
[25]
Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF pheno-type[J]. JACC Heart Fail, 2023, 11(8 Pt 1): 1000-1010.
[26]
Kosiborod MN, Verma S, Borlaug BA, et al. Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial[J]. Circulation, 2024, 149(3): 204-216.
[27]
Kobak KA, Chiao YA. Semaglutide in heart failure with pre-served ejection fraction: benefits above and beyond weight loss[J]. JACC Basic Transl Sci, 2023, 8(10): 1315-1317.
[28]
Withaar C, Meems LMG, Nollet EE, et al. The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF[J]. JACC Basic Transl Sci, 2023, 8(10): 1298-1314.
[29]
Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial[J]. J Am Med Assoc, 2021, 325(14): 1414-1425.
[30]
Smits MM, van Raalte DH. Safety of semaglutide[J]. Front Endocrinol (Lausanne), 2021, 12: 645563.
[31]
Romera I, Cebrián-Cuenca A, Álvarez-Guisasola F, et al. A review of practical issues on the use of glucagon-like peptide-1 receptor agonists for the management of type 2 diabetes[J]. Diabetes Ther, 2019, 10(1): 5-19.
[32]
Masson W, Lobo M, Barbagelata L, et al. Acute pancreatitis due to different semaglutide regimens: an updated meta-analysis[J]. Endocrinol Diabetes Nutr (Engl Ed), 2024, 71(3): 124-132.
[33]
Nagendra L, Bg H, Sharma M, et al. Semaglutide and cancer: a systematic review and meta-analysis[J]. Diabetes Metab Syndr, 2023, 17(9): 102834.
[34]
Ouellette S, Frias G, Shah R, et al. Dermal hypersensitivity reaction to semaglutide: two case reports[J]. J Drugs Dermatol, 2023, 22(4): 413-416.
[35]
He L, Wang J, Ping F, et al. Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials[J]. J Am Med Assoc Intern Med, 2022, 182(5): 513-519.
[36]
赵翊如, 方振威, 张琳, 等. 基于FAERS数据库的成人使用司美格鲁肽的临床研究[J]. 中国临床药理学杂志, 2024, 40(2): 264-268.
2024年第45卷第10期
16
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.10.016
  • 接收时间:2024-06-14
  • 首发时间:2026-11-17
  • 出版时间:2024-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-06-14
基金
作者信息
    中国人民解放军第九八九医院派驻门诊部,河南 洛阳 471003
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.10.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏